학술논문
A genetically defined signature of responsiveness to erlotinib in early-stage pancreatic cancer patients: Results from the CONKO-005 trial
Document Type
Article
Author
Source
In eBioMedicine April 2021 66
Subject
Language
ISSN
2352-3964